Prostate cancer starts when cells in the prostate gland grow out of control. Those cells can spread to other parts of the body and affect healthy tissue. This can happen for several reasons. When ...

Adding external-beam radiation to brachytherapy does not improve 5-year freedom from progression (FFP) for men with intermediate-risk prostate cancer, but it does increase treatment toxicity. The ...

Previous research has suggested that androgen-deprivation therapy (ADT) improves survival when added to radiotherapy in men with locally advanced, stage T3 or T4 prostate cancer (Bria E et al.Cancer.

The treatment of localized prostate cancer is controversial, with treatment options including radical prostatectomy, radiotherapy, and active surveillance. Furthermore, the effect of patient age on ...

EBRT plus brachytherapy does not improve outcomes over brachytherapy alone in patients with intermediate-risk prostate cancer, a phase 3 trial suggests. External beam radiation therapy (EBRT) plus ...

EBRT with or without STAD showed similar 15-year PCSS and OS rates in IRPC patients, with high PSA failure rates observed. Multivariate analysis indicated greater side effects in the STAD group ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Men with localized prostate cancer who received high-dose external radiation therapy were less likely to have cancer recurrence than men who received conventional-dose radiation therapy, according to ...